Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Life Sciences|May 12, 1986
The effect of thioridazine on haloperidol induced behavioral hypersensitivityH L Klawans, P M Carvey, D Nelson, et al.
Neurology|July 1, 1978
Lergotrile in the treatment of parkinsonismH L Klawans, C G Goetz, P Volkman, et al.
Annals of Neurology|September 1, 1996
Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's diseaseN Diederich, C Hilger, C G Goetz, et al.
Clinical Neuropharmacology|June 1, 1993
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystoniaA S Buchman, C L Comella, G T Stebbins, et al.
Neurology|August 1, 1989
Agonist substitution in advanced Parkinson's diseaseC G Goetz, K M Shannon, C M Tanner, et al.
Neurology|May 1, 1987
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet)C G Goetz, C M Tanner, H L Klawans, et al.
Brain and Cognition|April 8, 2000
Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's diseaseG T Stebbins, J D Gabrieli, K M Shannon, et al.
Clinical Neuropharmacology|December 1, 1987
Amantadine and motor fluctuations in chronic Parkinson's diseaseK M Shannon, C G Goetz, V S Carroll, et al.
Neurology|December 31, 1997
Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating ScaleD A Bennett, K M Shannon, L A Beckett, et al.
Clinical Neuropharmacology|April 6, 2001
Estrogen supplementation in the posthypoxic myoclonus rat modelK Kompoliti, C G Goetz, T Q Vu, et al.
Pageof 19